Literature DB >> 2329276

Transforming growth factor-beta 1 is a costimulator for IgA production.

P H Kim1, M F Kagnoff.   

Abstract

Transforming growth factor-beta 1 (TGF-beta 1) belongs to a family of polypeptides involved in the regulation of cell growth and differentiation. We have examined the ability of TGF-beta 1 to regulate isotype specific Ig secretion by murine spleen B cells. TGF-beta 1, in the presence of rIL-2, induced a synergistic 10-fold or greater increase in IgA secretion by LPS-stimulated spleen B cells. TGF-beta 1 alone had little to no effect on IgA secretion. In contrast, TGF-beta 1, with or without rIL-2, markedly inhibited IgG1 and IgM secretion under the same conditions. The costimulatory activity of TGF-beta 1 and rIL-2 on IgA secretion was seen in cultures of surface IgA negative B cells and was inhibited by anti-TGF-beta 1 antibody in a dose dependent manner. Vicia villosa agglutinin non-adherent Peyer's patch T cells, which secrete IL-2, also synergized with TGF-beta 1 and could substitute for the activity of LPS and rIL-2 on the IgA response. Finally, IL-5 added after 2 days of culture, but not at the beginning of culture, synergized with TGF-beta 1 on the IgA response. These studies indicate that TGF-beta 1 can interact with other lymphokines and selectively modulate the IgA response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2329276

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis.

Authors:  H L Weiner
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.

Authors:  H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Retinoic acid enhances lactoferrin-induced IgA responses by increasing betaglycan expression.

Authors:  Jeong-Min Lee; Young-Saeng Jang; Bo-Ra Jin; Sun-Jin Kim; Hyeon-Jin Kim; Bo-Eun Kwon; Hyun-Jeong Ko; Sung-Il Yoon; Geun-Shik Lee; Woan-Sub Kim; Goo-Young Seo; Pyeung-Hyeun Kim
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

4.  Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa.

Authors:  H A Haeberle; M Kubin; K B Bamford; R Garofalo; D Y Graham; F El-Zaatari; R Karttunen; S E Crowe; V E Reyes; P B Ernst
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

5.  Transforming growth factor-beta in a model of IgA switching.

Authors:  D Y Kunimoto
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

6.  Effects of transforming growth factor beta-1 and interleukin-5 on IgA isotype switching at the clonal level.

Authors:  M F Kagnoff; P H Kim
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

7.  Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling.

Authors:  Y-S Jang; G-Y Seo; J-M Lee; H-Y Seo; H-J Han; S-J Kim; B-R Jin; H-J Kim; S-R Park; K-J Rhee; W-S Kim; P-H Kim
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

Review 8.  Heterogeneity and plasticity of T helper cells.

Authors:  Jinfang Zhu; William E Paul
Journal:  Cell Res       Date:  2009-12-15       Impact factor: 25.617

9.  Augmentation of natural killer cell activity in mice by oral administration of transforming growth factor-beta.

Authors:  S Ishizaka; M Kimoto; S Kanda; S Saito
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

10.  Transforming growth factor-beta (TGF-beta) in human milk.

Authors:  S Saito; M Yoshida; M Ichijo; S Ishizaka; T Tsujii
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.